Fall 2024 COVID-19 guide: The status of COVID in Canada, available vaccines — and strains expected to dominate winter

Health Canada authorizes three updated COVID vaccines ahead of winter and growing concern over new variants.

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Contact a qualified medical professional before engaging in any physical activity, or making any changes to your diet, medication or lifestyle.

close up of man getting a vaccine
Three newly-approved COVID-19 vaccines are now available for Canadians this fall. (Image via Getty Images)

Pfizer-BioNTech’s updated COVID-19 vaccine was approved by Health Canada on Tuesday. The updated formula was designed to help target the KP.2 variant and sub variants expected to dominate fall and winter.

Pfizer Canada said the vaccine will be available in “pharmacies and vaccination centres across the country in the fall.”

Earlier this month, Health Canada approved an updated vaccine from Moderna as well as Novavax’s protein-based vaccine, Nuvaxovid.

Here's everything you need to know about the current state of COVID in Canada — plus all your COVID questions answered.


The latest vaccine approval comes as Health Canada reports “most COVID-19 indicators are stable at elevated levels compared to spring.” Although trends vary across provinces and territories, outbreaks have been “slowly increasing” since spring. As of Sept. 25, COVID activity levels were reported as “high” for Ontario and Quebec.


Currently, the KP.3 and KP.3.1.1 FLiRT variants, derivatives of KP.1 and KP.2, are the most prevalent in Canada and the United States. As of Sept. 24, 72.1 per cent of COVID cases in Canada were from the KP.3.1.1 subvariant.

Positive Cassette rapid test for COVID-19. Close-up shot of woman's hand holding a negative test device.
What is COVID variant XEC? (Image via Getty Images)

Experts believe new variants related to KP.3 will continue to emerge, however there are other variants, like XEC, spreading in countries like Germany, the United Kingdom and Denmark.

XEC is considered a recombinant variant and features elements from both KS.1.1 and KP.3.3. Experts have said XEC’s spike protein mutation may make it more contagious, however it has not yet become a problem in Canada.

According to Health Canada, there have been cases of XEC variant recorded in Canada, but the number is so small it hasn’t been included in weekly variant tracking. It's unknown whether there are new symptoms associated with XEC.

In an interview with Yahoo Life, University of California, San Diego virologist Dr. Davey Smith said XEC is primed to become the latest subvariant to take over and "likely the one that will cause our winter wave" of COVID.


Doctor makes vaccination to senior woman with surgical mask
A new COVID vaccine is coming to Canada. (Image via Getty Images)

Many Canadians may be wondering if the new vaccine, which was formulated to protect against KP.2, will protect them against emerging variants, like KP.3 and the subvariant KP.3.1.1.

Dr. Donald Vinh an infectious disease specialist at McGill University tells Yahoo Canada it’s best to think of KP.2 variant and KP.3 (and future subvariants like KP.3.1.1.) as cousins since they share certain mutations in their spike proteins.

Vinh says the existing vaccines formulated to target KP.2 from Moderna and Pfizer have been successful in against their targeted strains. According to Vinh, as KP.3 and its variants continue to circulate, these vaccines “are likely going to have an impact in protecting against clinically important disease.”

“However, the variants are constantly in flux,” he says. “We are hearing about newer variants in other parts of the world that are less related/close to KP.2 or KP.3, and it will not be a surprise if some of these variants predominate, perhaps over the next 3-6 months, and for which the current vaccine formulations may or may not have weakened activity against them.”


In a previous interview with Yahoo Canada, Dr. Isaac Bogoch, an infectious disease specialist said symptoms of FLiRT variants (including KP.3 and its derivatives) are similar or same to those of other Omicron subvariants. "It's probably more of the same," he claimed, adding it's unlikely we'll see any surprises when it comes to symptoms.

COVID-19 symptoms continue to include:

  • Sore throat

  • Runny nose

  • Sneezing

  • Cough or cough that worsens

  • Shortness of breath

  • Difficulty breathing

  • Fever

  • Chills

  • Fatigue

  • Muscle or body aches

  • Loss of smell or taste

  • Headache

  • Abdominal pain, diarrhea and vomiting


No, the newly authorized COVID vaccines are not the same as a booster.

"Booster" shots are extra doses of a vaccine you've already received. Prior to Health Canada's latest approval, Canadians had the option to receive a booster of the previous formulation that targets Omicron XBB.1.5.

The latest formulas are considered an "updated vaccine" that helps the body build new responses to more recent variants.


Covid-19 Omicron, Corona Virus, Covid-19, Microbiology and Virology Concept, Nuremberg City, Bavaria, Franconia, Germany, Europe
Who should receive the latest COVID vaccine? (Image via Getty Images)

Back in May, the National Advisory Committee on Immunization published guidelines that strongly recommended a fall COVID shot for seniors, people with underlying medical conditions and anyone else in a higher-risk group. That includes pregnant people and those living in congregate living settings, like long-term care homes.

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in the fall of 2024" however, Nuvaxovid is only recommended for people 12 and over. The organization recommends a six-month interval between COVID vaccines, "with a minimum of three months from the last dose."


One of the issues with the emerging strains of COVID is detection. Healthcare settings using polymearse chain reaction (PCR) tests are more accurate at identifying the new strains of COVID. However, the rapid antigen tests are different. In a previous interview with Yahoo Canada, Vinh said its possible that some of the rapid tests that were manufactured years ago might not be able to detect the latest strains of COVID.

"It's possible that a person could pick up a rapid test, do it properly, and the test— which isn't expired— comes back negative," he explained. "There are other reasons why the test could be negative, but it's a little bit hit and miss."

These negative tests could potentially transmit the virus to someone at-risk. Wearing masks when you don't feel well around vulnerable persons and practicing social distances are encouraged.

Let us know what you think by emailing us, commenting below and tweeting @YahooStyleCA! Follow us on Twitter and Instagram.